The Importance of the Investigator Responsibilities and Legal Commitments in Drug and Device Clinical Research in Achieving a Clean Audit 2016
19 Apr 2016
Webinar
Key Topics
How following GCP helps assure a clean Audit / inspection?
The Investigators key role in the clinical research process
What are the main Investigator responsibilities?
The difference between AEs and SAEs and the reporting requirements
What is the legal language of the FDA form 1572 or Device equivalent?
How is the investigator responsible for the IC process?
Why is Financial Disclosure information important?
Who should Attend
Attendees from:
Clinical Research Scientists (PKs, Biostatisticians)
Principal Investigators and Sub Investigators
Clinical Research Associates (CRAs) and Coordinators (CRCs)
Safety Nurses
QA / QC Auditors and Staff
Recruiting Staff
Clinical Research Data Managers
Past Events
The Importance of the Investigator Responsibilities and Legal Commitments in Drug and Device Clinical Research in Achieving a Clean Audit 2016 - 19 Apr 2016, Webinar (58704)
The Importance of the Investigator Responsibilities and Legal Commitments in Drug and Device Clinical Research in Achieving a Clean Audit 2026
Important
Please, check "The Importance of the Investigator Responsibilities and Legal Commitments in Drug and Device Clinical Research in Achieving a Clean Audit" official website for possible changes, before making any traveling arrangements
